Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Search Results

Your search for the word "dupilumab" returned 23 results
1 - 15 of 23 Content Items
1 January 2017

Does dupilumab pass the test for atopic dermatitis?

Physician Editor Abby Van Voorhees, MD, talks with Eric L. Simpson, MD, MCR about his recent New England Journal of Medicine article. ... Journal of Medicine article, " ... Two Phase 3 Trials of Dupilumab versus Placebo in Atopic... negative effects on barrier function creating a vicious cycle. ... Dr. Van Voorhees: Dupilumab
1 January 2017

From the editor

Archive | Dermatology World Weekly Archives ... Year ... Issue ... Download PDF January 2017... places Acta Eruditorum Does dupilumab pass the test for atopic dermatitis? Acta Eruditorum Video
1 January 2017

January 2017

Archive | Dermatology World Weekly Archives ... Year ... Issue ... Download PDF January 2017... places Acta Eruditorum Does dupilumab pass the test for atopic dermatitis? Acta Eruditorum Video
1 January 2017

Video: Trending in research

Dr. Nada Elbuluk discusses patient preferences in dermatologist attire, as well as patient preferences during skin cancer screening examinations. ... hot? Cracking the Code Special codes for special places Acta Eruditorum Does dupilumab pass the test
1 December 2016

Playing the angles

New treatments target potential pathways for atopic dermatitis. ... disease control." ... Dupilumab – Interleukin (IL) 4/IL-13 Dupilumab is often the first biologic that comes to mind for atopic dermatitis. "Dupilumab really represents a potential paradigm shift
1 January 2017

Some exclusions apply

CMS says 2,300 dermatologists don't have to do MIPS. Are you one of them? ... dupilumab pass the test for atopic dermatitis? Acta Eruditorum Video: Trending in research Legally
1 June 2017

What's hot?

Members of DW's Editorial Advisory Workgroup share exciting news from across the specialty. ... ANP-BC ... Well, it’s finally here! ... On March 28, the FDA approved dupilumab (Dupixent, Regeneron... of dupilumab were established in three placebo-controlled clinical trials with a total of 2,119 adult
22 June 2017

Industry Non-CME Programs

The INC programs do not qualify for Continuing Medical Education (CME) credit and are not part of the Academy's Meeting as planned by the its Scientific Assembly Committee. All content of the programs are under the control of the sponsoring company. ... July 29, 2017 ... Session title: Now Approved DUPIXENT ... ® ... (dupilumab) ... Sponsoring company
1 January 2017

How do you overcome difficulties in carrying out treatment plans due to insurance?

Dermatology World's readers answer a monthly question addressing a particular challenge within the specialty. ... for special places Acta Eruditorum Does dupilumab pass the test for atopic dermatitis? Acta Eruditorum
1 January 2017

A New Year: Reflecting and refocusing

Academy President Abel Torres, MD, JD, discusses where the Academy is headed in 2017. ... the Code Special codes for special places Acta Eruditorum Does dupilumab pass the test for atopic
1 September 2015

Ripe for the picking

Experts profile the future of biologic treatments ... is dupilumab." ... Dupilumab — developed by Regeneron Pharmaceuticals and Sanofi — is a monoclonal antibody... was reversed after only four weeks of dupilumab treatment, showing a dose effect molecular and histologic
1 March 2015

From bench to bedside

Dermatology World looks at new discoveries in dermatology that will influence clinical practice in the future. ... dermatitis, bad eczema, and there’s a drug in development, dupilumab, which will be dramatically effective," Dr. Lebwohl said. ... Phase II trials have shown that dupilumab, which blocks IL-4 and IL-13
1 January 2017

Special codes for special places

Columnist Alex Miller, MD, gives coding tips for special biopsy sites on the body. ... for special places Acta Eruditorum Does dupilumab pass the test for atopic dermatitis? Acta Eruditorum
1 February 2016

What's hot?

Members of DW's Editorial Advisory Workgroup share exciting news from across the specialty. ... are requisite drivers of atopic dermatitis ( ... N Engl J Med 2014; 371:130-139 ). Dupilumab
1 October 2016

What's hot?

Members of DW's Editorial Advisory Workgroup share exciting news from across the specialty. ... MSN, ANP-BC While many dermatology providers are anxiously awaiting the approval of dupilumab... versus daily application (BCC: RR 1.03, 95 percent CI 0.74 to 1.43 / SCC: RR 0.88, 95 percent CI
1 - 15 of 23 Content Items